RUNX3 gene expression confers an independent Overall survival advantage in non-M3 adult acute myeloid leukemia patients in Egypt.

Clinical Significance of NPM1 A and Non A Mutations and Its Relation to The ARF/P53 Pathway in Egyptian Acute Myeloid Leukemia Patients

The Role of β-Catenin and c-Myc Dysregulation in Acute Myeloid Leukemia: A Study of Egyptian Patients

Evaluation of ADAM28 expression in adult Egyptian Acute Myeloid Leukemia patients and its impact on outcome

Outcome of acute myeloid leukemia with recurrent cytogenetic abnormalities; A retrospective study in South Egypt Cancer Institute Rania Bakry;1AsmaaOmar,2Abeer M. Darwish,3Rania H

NPM1 Gene Expression as a Molecular Prognostic Marker in Acute Myeloid Leukemia Among Egyptian Patients

Assessment of INPP4B Expression Level in Acute Myeloid Leukemia Patients and Its Prognostic Significance. An Egyptian Study

Gene Polymorphism of CYP2B6 and Susceptibility to Acute Myeloid Leukemia in Egypt

CD47 Expression in Egyptian Patients with Acute Myeloid Leukemia

Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt